Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
Clinical trial NCT02135029 · COMPLETED
Trial details
- NCT number
- NCT02135029
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.